Clinical Trial

Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study

No Longer Available
View on ClinicalTrials.gov →
Summary
This Program is designed to provide continued access BIA 28-6156, free and compassionately for an eligible patient previously enrolled in the BIA 28-6156-201 (ACTIVATE) clinical study and that had completed the study.
Protocol Amendment History 1 change
critical Trial status changed: Available → No Longer Available 2026-08-11
Trial Details
NCT Number NCT07522606
Lead Sponsor Bial R&D Investments, S.A.
Conditions Parkinson Disease
Updated on ClinicalTrials.gov 2026-08-10